Clinical trial
Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once…
NCT00453063 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00453063 |
|---|---|
| Title | Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED) |
| Official title | Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Seasonal Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | mometasone furoate, Placebo |
| Enrollment | 426 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Mar 28, 2007 |
| Last update posted | Feb 9, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: